Pharmaceutics (Nov 2023)

Photodynamic Therapy-Induced Anti-Tumor Immunity: Influence Factors and Synergistic Enhancement Strategies

  • Wenxin Chou,
  • Tianzhen Sun,
  • Nian Peng,
  • Zixuan Wang,
  • Defu Chen,
  • Haixia Qiu,
  • Hongyou Zhao

DOI
https://doi.org/10.3390/pharmaceutics15112617
Journal volume & issue
Vol. 15, no. 11
p. 2617

Abstract

Read online

Photodynamic therapy (PDT) is an approved therapeutic procedure that exerts cytotoxic activity towards tumor cells by activating photosensitizers (PSs) with light exposure to produce reactive oxygen species (ROS). Compared to traditional treatment strategies such as surgery, chemotherapy, and radiation therapy, PDT not only kills the primary tumors, but also effectively suppresses metastatic tumors by activating the immune response. However, the anti-tumor immune effects induced by PDT are influenced by several factors, including the localization of PSs in cells, PSs concentration, fluence rate of light, oxygen concentration, and the integrity of immune function. In this review, we systematically summarize the influence factors of anti-tumor immune effects mediated by PDT. Furthermore, an update on the combination of PDT and other immunotherapy strategies are provided. Finally, the future directions and challenges of anti-tumor immunity induced by PDT are discussed.

Keywords